Euronext N.V. (ETR:ENXB)
118.20
-0.90 (-0.76%)
At close: Jan 29, 2026
Euronext Revenue
Euronext had revenue of 438.20M EUR in the quarter ending September 30, 2025, with 10.57% growth. This brings the company's revenue in the last twelve months to 1.78B, up 12.18% year-over-year. In the year 2024, Euronext had annual revenue of 1.63B with 10.32% growth.
Revenue (ttm)
1.78B
Revenue Growth
+12.18%
P/S Ratio
6.63
Revenue / Employee
731.51K
Employees
2,455
Market Cap
11.79B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.63B | 152.21M | 10.32% |
| Dec 31, 2023 | 1.47B | 55.90M | 3.94% |
| Dec 31, 2022 | 1.42B | 120.16M | 9.25% |
| Dec 31, 2021 | 1.30B | 414.34M | 46.85% |
| Dec 31, 2020 | 884.32M | 205.21M | 30.22% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Uniper SE | 66.33B |
| Continental Aktiengesellschaft | 39.54B |
| Deutsche Lufthansa AG | 39.35B |
| Fresenius Medical Care AG | 19.64B |
| Covestro AG | 13.40B |
| GEA Group Aktiengesellschaft | 5.44B |
| Symrise AG | 4.99B |
| DWS Group GmbH & Co. KGaA | 4.36B |
Euronext News
- 9 days ago - CZECHOSLOVAK GROUP announces full exercise of Over-Allotment Option in connection with its Initial Public Offering on Euronext Amsterdam - GlobeNewsWire
- 10 days ago - CZECHOSLOVAK GROUP announces admission to trading on Euronext Amsterdam - GlobeNewsWire
- 14 days ago - IBA selected by MD Anderson Cancer Center to supply three ProteusONE systems - Wallstreet:Online
- 25 days ago - EXAIL TECHNOLOGIES: Exail Technologies' convertible bond labelled "European Defence Bond" by Euronext - Finanz Nachrichten
- 27 days ago - Galapagos NV: Galapagos Announces Board Decision to Initiate Wind-Down of Cell Therapy Activities - Finanz Nachrichten
- 5 weeks ago - IBA signs contract for a three-room ProteusPLUS solution to be installed at the Seoul St. Mary’s Hospital - Wallstreet:Online
- 6 weeks ago - Campine invests in third-generation antimony recycling and transitions to Euronext Brussels continuous market - GlobeNewsWire
- 7 weeks ago - IBA SA: Proton Therapy New Standard of Care for Patients with Oropharyngeal Cancer - Finanz Nachrichten